Global - Drug Design - An Important Aspect of the R&D Process

PipelineReview.com
September 6, 2010

The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development process, as the value of a medicine has to be communicated to both patients and healthcare professionals. Patient expectations will rise as the shift towards taking greater responsibility for personal healthcare plays out, driven by the increasing individuality of modern drugs.

...According to the New England Healthcare Institute (NEHI), approximately 30-50% of patients in the US do not take medicines as prescribed. Reasons for not following the proper medication regimen include: unpleasant side effects; confusion; forgetfulness; language barriers; and feeling 'too good' to need medicine. Additionally, non-adherence to medicine regimens results in US$100bn in excess hospitalisations and alongside sub-optimal prescribing, drug administration and diagnosis can result in up to US$290bn in increased medical costs.

Link to Full Article: http://www.pipelinereview.com/index.php/2010090636654/Expert-View/Global-Dr…